These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. Gupta AK Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Gupta AK J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137 [TBL] [Abstract][Full Text] [Related]
4. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Gupta AK; Shear NH Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975 [TBL] [Abstract][Full Text] [Related]
5. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine. Angello JT; Voytovich RM; Jan SA Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095 [TBL] [Abstract][Full Text] [Related]
6. Current trends in onychomycosis therapy: a literature review. Hecker D Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835 [TBL] [Abstract][Full Text] [Related]
7. The new oral antifungal agents for onychomycosis of the toenails. Gupta AK; Shear NH J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model. Marchetti A; Piech CT; McGhan WF; Neugut AI; Smith BT Clin Ther; 1996; 18(4):757-77; discussion 702. PubMed ID: 8879902 [TBL] [Abstract][Full Text] [Related]
9. The use of oral antifungal agents to treat onychomycosis. Gupta AK; Ryder JE Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199 [TBL] [Abstract][Full Text] [Related]
10. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Gupta AK; Ryder JE; Johnson AM Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339 [TBL] [Abstract][Full Text] [Related]
11. Current issues in onychomycosis. Trépanier EF; Amsden GW Ann Pharmacother; 1998 Feb; 32(2):204-14. PubMed ID: 9496407 [TBL] [Abstract][Full Text] [Related]
12. A questionnaire study on the management of onychomycosis: a Canadian perspective. Gupta AK; Shear NH Int J Dermatol; 1998 Jun; 37(6):457-60. PubMed ID: 9646138 [TBL] [Abstract][Full Text] [Related]
13. [Oral treatment of onychomycosis of the toe nails; comparison of cost effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]. Jacobs AE Ned Tijdschr Geneeskd; 1995 Apr; 139(17):904-5. PubMed ID: 7739744 [No Abstract] [Full Text] [Related]
14. Oral therapy for onychomycosis: an evidence-based review. de Sá DC; Lamas AP; Tosti A Am J Clin Dermatol; 2014 Feb; 15(1):17-36. PubMed ID: 24352873 [TBL] [Abstract][Full Text] [Related]
15. Oral therapeutic agents in fungal nail disease. Roberts DT J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514 [TBL] [Abstract][Full Text] [Related]
16. New therapies for onychomycosis. Odom RB J Am Acad Dermatol; 1996 Sep; 35(3 Pt 2):S26-30. PubMed ID: 8784308 [TBL] [Abstract][Full Text] [Related]
17. Newer systemic antifungal drugs for the treatment of onychomycosis. Chiritescu MM; Chiritescu ME; Scher RK Clin Podiatr Med Surg; 1996 Oct; 13(4):741-58. PubMed ID: 8902341 [TBL] [Abstract][Full Text] [Related]
18. [Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]. Bergman W; Rutten FF Ned Tijdschr Geneeskd; 1994 Nov; 138(47):2346-50. PubMed ID: 7969635 [TBL] [Abstract][Full Text] [Related]